Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teladoc Health, Inc. Common Stock (NY: TDOC )

13.77 +0.66 (+5.03%)
Official Closing Price Updated: 4:10 PM EST, Feb 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teladoc Health, Inc. Common Stock

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
48 49 Next >
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
Via Benzinga
Is It Finally Time to Sell Teladoc?
Execution is lacking, again. 
Via The Motley Fool
Why Enovix Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
eBay, Unity Software, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Earnings Outlook For Teladoc Health
Via Benzinga
Better Buy: Teladoc vs. Doximity
Both of these innovative healthcare stocks are cheap today. 
Via The Motley Fool
3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop Buying
Beaten-down growth stocks were popular buys during the fourth quarter for some of the brightest billionaire money managers. 
Via The Motley Fool
Teladoc Health (TDOC) Q4 2022 Earnings Call Transcript
TDOC earnings call for the period ending December 31, 2022. 
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
After-Hours Alert: Why Teladoc Stock Is Diving
Teladoc Health Inc (NYSE: TDOC) shares are trading lower in Tuesday's after-hours session after the company reported  
Via Benzinga
Teladoc Health Reports Fourth Quarter and Full Year 2022 Results
From Teladoc Health, Inc.
Via GlobeNewswire
Will This Beaten-Down Stock Bounce Back? 3 Things to Know
The stock has started 2023 off on the right foot -- with a rebound. 
Via The Motley Fool
1 Reason to Buy Teladoc Stock, and 1 Reason to Sell
Is the worst over for the healthcare company? 
Via The Motley Fool
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
3 Bargain Stocks Cathie Wood Loves
These top growth stocks may be facing choppy waters, but investors would be mistaken to count them out for good. 
Via The Motley Fool
3 Stocks Ready to Bounce Back
These stocks could deliver explosive gains -- and gains that should last. 
Via The Motley Fool
Going Stock Shopping for 2023? 2 No-Brainer Buying Opportunities in a Growth Stock Bear Market
It's more important than ever for investors to dig deeper beyond looking at just the share price. 
Via The Motley Fool
2 Cathie Wood Stocks to Buy Without Hesitation in 2023
Growth stocks have had a slew of better market days in the first part of 2023, but it's important to be selective. 
Via The Motley Fool
3 Resilient Stocks to Help Solidify Your Portfolio in 2023
Choose companies with strong fundamentals that can withstand storms and continue to thrive. 
Via The Motley Fool
3 Unstoppable Growth Stocks to Buy If There's a Stock Market Sell-Off
Growth stocks are volatile, but some investing gems remain amid the bunch. 
Via The Motley Fool
3 Cathie Wood Stocks That Could Deliver Bigger Gains Than the Market
Investing in innovation can still be a winning strategy. 
Via The Motley Fool
A Bull Market Is Coming. Should You Return to Growth Stocks?
Growth stocks could be among the first to rally in a bull market. 
Via The Motley Fool
3 Cathie Wood Stocks Still Worth a Look From Her Pummeled Portfolio
Amid the most beaten-down stocks in the Ark portfolio, there are some Cathie Wood stocks worth buying for the long-term. 
Via InvestorPlace
2 Beaten-Down Stocks to Buy in 2023 and Hold for at Least 5 Years
Etsy and Teladoc are two growth stocks that still have plenty of long-term viability. 
Via The Motley Fool
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
2 Top Stocks to Buy Without Hesitation in 2023
Looking beyond the bear market-driven share price drop is key. 
Via The Motley Fool
2 Explosive Growth Stocks to Buy in 2023
Growth stocks aren't thrilling investors like they did in 2020, but hope may be on the horizon. 
Via The Motley Fool
Nasdaq Bear Market: 5 Special Growth Stocks You'll Regret Not Buying on the Dip
A 33% plunge in the Nasdaq Composite is the perfect time to go shopping for game-changing businesses trading at a discount. 
Via The Motley Fool
3 Disruptors I Love Right Now
Disruptive companies have been among the most beaten-down, but could provide the best upside moving forward. 
Via The Motley Fool
Cathie Woods' Ark Innovation ETF Set To Rebound in 2023?
Can gains in Tesla, Zoom, Exact Sciences, and other growth stocks set the stage for Cathie Woods' Ark Innovation Fund to stage a comeback in 2023? 
Via MarketBeat
Topics ETFs
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
48 49 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.